On March 14, 2022, Raymond Pratt notified Rockwell Medical, Inc. of his decision to resign as the Company's Chief Development Officer, effective as of March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.755 USD | -0.85% | -3.04% | -7.14% |
05-30 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
05-14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.14% | 53.66M | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Raymond Pratt Resigns from Rockwell Medical, Inc. as Chief Development Officer, Effective March 25, 2022